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1. INTRODUCTION 
 
The end of the 20th century marks the development of techniques that enable rapid 
data production in life sciences and consequently development of omics approaches. Omics 
refers to collective characterization and quantification of pools of biological molecules that 
translate into the structure, function, and dynamics of an organism or organisms. One of the 
omics disciplines is functional genomics, the aim of which is to understand the complex 
relationship between genotype and phenotype on a global (genome-wide) scale. Functional 
genomics studies investigate a range of processes such as transcription, translation and 
epigenetic regulation, as opposed to the static aspects of genomic information, such as DNA 
sequence or structure, that fall under the domain of genomics. To explore the cappacities of 
functional genomics approaches, new methods had to be invented with the ability to assess 
function on a genomic level that are statistically robust and high-throughput at the same time. 
The aim of this review is to give an overview of the most common laboratory techniques used 
in functional genomics, starting on the DNA and RNA level and finishing with various 
methods that aim at discovering interactions, such as protein-DNA and chromatin 
interactions. 
 
2. GENOMICS – DNA SEQUENCING 
 
DNA sequencing is the process of determining the order of bases in a length of DNA. 
Whole genome sequencing focuses on sequencing all the DNA in an organism's genome. 
During the last few decades an enormous progress has been made in the development of new 
sequencing technologies, with the aim of making sequencing faster and cheaper. Although 
DNA sequencing itself does not in the real sense fall within the scope of functional genomics, 
sequenced genomes are a prerequisite for any further functional investigation and therefore 
DNA sequencing deserves to be covered in this review. The era of DNA sequencing started 
with the Sanger method, which is based on the selective incorporation of flourecently labeled 
chain-terminating dideoxynucleotides (ddNTPs) by DNA polymerase during a PCR reaction. 
In the resulting mixture of DNA molecules of various sizes, the different fluorescent dyes 
mark different ddNTPs at the end of each DNA molecule. The DNA sequence is determined 
by high-resolution electrophoretic separation of DNA fragments and assessment of their 
length and ddNTP identity. Modifications of this method dominated the sequencing industry 
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for almost two decades and enabled sequencing of the first finished-grade human genome 
sequence. 
The Sanger method led to a number of monumental accomplishments but it was also 
slow, expensive and labor-intensive. Because of this, newer methods, referred to as the next-
generation sequencing (NGS), were developed. The advancements in NGS are reflected in 
increasing output per run, read lengths and accuracy of base-calling as well as decreasing the 
costs of sequencing. Second- and third-generation sequencers offered the ability to produce an 
enormous volume of data cheaply. As a result, the rate limiting step in answering to biological 
questions today is the sequence analysis, not the sequence production. One consequence of 
the sequencing revolution is the revitalization of bioinformatics, predominantly in efforts 
aimed at data analysis and interpretation. 
Although each platform is different in its specifics, all NGS  devices share certain 
attributes. Firstly, the preparatory steps are fewer and simpler than for Sanger sequencing. 
Instead of beginning with bacterial cloning and DNA isolation, NGS experiment begins with 
the creation of template library. Templates are formed by ligating platform-specific synthetic 
DNA molecules (adapters) onto the ends of the fragment population to be sequenced. 
Secondly, the templates need to be immobilized on a solid surface for amplification by a 
polymerase-mediated reaction. Lastly, the sequencing reactions are carried out in a series of 
repeating steps and the products are detected automatically. 
Sequencing technologies include a number of methods that are grouped broadly as 
template preparation, sequencing, imaging and data analysis. Current methods for template 
preparation generally involve randomly breaking genomic DNA into smaller sizes from which 
the templates are created. The immobilization of spatially separated templates allows 
thousands to billions of sequencing reactions to be performed simultaneously. Templates can 
be clonally amplified or single-molecule. Latter approach does not require PCR, which 
creates mutations that can be mistaken for single nucleotide polymorphisms (SNPs). 
Moreover, AT- and GC-rich sequences show amplification bias so the quantitative 
approaches, such as RNA-seq, perform better with single-molecule templates. 
In the past couple of years, Illumina sequencers have gained most of the market share 
due to the best balance between read lengths, error rates and cost as well as rapid 
improvements in sequencing chemistry and availability of more extensive bioinformatics 
tools. Because of this, I believe that the Illumina platform deserves to be described in this 
review as an example of distinct sequencing strategy. During template preparation, Illumina 
uses the so called solid-phase amplification procedure, which is composed of two steps: initial 
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priming and extending of the single-stranded, single-molecure template, and bridge 
amplification of the immobilized template with immediately adjacent primers to form 
clusters. In the sequencing and imaging step Illumina uses the cyclic reversible termination 
technology, which comprises nucleotide incorporation, fluorescence imaging and cleavage. 
DNA polymerase bound to the primed template adds just one fluorescently modified 
nucleotide, which represents complement of the template base. The remaining unincorporated 
nucleotides are then washed away and the imaging is performed to determine the identity of 
the incorporated nucleotide. This is followed by a cleavage step, which removes the 
terminating/inhibiting group and the fluorescent dye. 
After NGS reads have been generated, they are aligned to a known reference sequence 
or assembled de novo. The choice of the strategy depends on biological application, cost, 
effort and time considerations.  Alignment to a reference sequence is cheaper, faster and less 
time-consuming but it is also limited by factors such as placing reads within repetitive regions 
and nonexistent corresponding regions in the reference sequence. These factors can be 
partially overcome by using mate-pair reads, increasing the reading coverage (which results in 
increasing contig length and decreasing ambiguities in an assembly) and combining different 
NGS platform reads. 
Genome assembly is followed by genome annotation, the process of identifying genes 
and their intron-exon structures. Although the sequencing has become easier with the 
introduction of NGS technologies, genome annotation has become more challenging. There 
are several reasons for this: shorter read lengths of NGS technologies, exotic nature of many 
recently sequenced genomes and the need to update already annotated genomes with new 
data. 
The first step towards the successful annotation of a genome is to determine whether 
its assembly is ready for annotation. There are several summary statistics that can be used to 
assess the completeness and contiguity of a genome assembly – N50, average gap size of a 
scaffold and average number of gaps per scaffold. The most commonly used summary 
statistics is N50. A contig N50 is calculated by summarizing the lengths of contigs starting 
from the longest one, until the sum equals one half of all contigs in that assembly. The contig 
N50 is the length of the shortest contig in this list. The scaffold N50 is calculated in the same 
manner but uses scaffolds instead of contigs. Although there are no strict rules, an assembly 
with an N50 scaffold length that is gene-sized is a decent target for annotation because this 
means that around 50% of the genes will be contained on a single scaffold. If an assembly is 
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incomplete or its N50 scaffold length is too short, additional shotgun sequencing is 
recommendable. 
Generally, genome-wide structural annotation can be divided into two phases, 
computational and annotation phase. The so called computational phase includes repeat 
identification and masking followed by alignment with already annotated sequences, such as 
ESTs, RNA-seq data and protein and DNA sequences from databases. Repeats complicate 
genome annotation and should therefore be masked. The term masking implies transforming 
every nucleotide identified as a repeat to an 'N' or, for soft masking, lower case a, t, c or g. 
The importance of repeat masking cannot be overemphasized: unmasked repeats can produce 
a number of false BLAST alignments. On top of that, many transposon ORFs look like true 
host genes and can be added as additional exons to gene predictions. Gene prediction can be 
ab initio, using mathematical models rather than external evidence, or evidence-driven. Most 
of today's gene prediction tools use combination of ab initio and evidence-driven methods. 
The annotation phase includes obtaining a synthesis of alignment-based evidence with 
ab initio gene predictions to obtain a final set of gene annotations. Traditionally, this was 
done manually. This is the most precise but also the most time-consuming way of gene 
prediction so more and more laboratories are using automated annotation pipelines. This 
implies running a number of different gene finders and using a chooser algorithm (also known 
as combiner) to select the prediction whose intron-exon structure best represents the 
consensus of the models.  
The last step of the annotation is the visualization of the annotation data. There are 
several commonly used output formats for describing annotations, including GenBank, GFF3, 
GTF and EMBL. FASTA format shouldn't be used as the output format for annotations 
because it is insufficiently informative and enables only a small subset of possible 
downstream analyses. There is one more essential part of the annotation process, and that is 
the quality control. Once a genome is annotated, it doesn't mean that all the annotations are 
correct – even the most precise gene predictors and pipelines manage to accomplish the 
accuracy of around 80%. Flawed annotations are dangerous because they are transferred to 
future annotations and can lead to false conclusions when used in research. 
Genome annotations find their use in medicine (discovery of clinically significant 
variants, treatment personalization), in seq-based methods (ChIP-seq, DNase-seq, methyl-seq, 
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RNA-seq), metagenomics and are a prerequisite for all downstream investigations, such as 
transcriptomics, proteomics and epigenomics. 
Despite their limitations, advances in next-generation sequencing have been so rapid 
that they have ceased to amaze. New single-molecule methods, particularly nanopore 
sequencing, promise to significantly expand the realm of possibilities by greatly decreasing 
costs. Recently, a startup called Oxford Nanopore announced the launch of a new third 
generation single-molecule sequencing platform. By moving single-pore sequencing 
technologies to market, Oxford Nanopore promised read lengths orders of magnitude longer 
than existing technologies, together with low per-base costs, and a tiny futuristic USB-
powered sequencer. The hand-held $1000 sequencer, with a simple library preparation 
process, promised to democratize sequencing, making it affordable to a larger community and 
perhaps even to citizen-scientists. 
 
3. TRANSCRIPTOME PROFILING 
The transcriptome is the complete set of transcripts in a cell, and their quantity, for a 
specific developmental stage or physiological condition. Various technologies have been 
developed to deduce and quantify the transcriptome. Traditionally wide-used set of methods 
can be characterized as hybridization-based approaches, with the most commonly used 
application being microarrays. Microarray is a hybridization of a nucleic acid sample (target) 
to a very large set of oligonucleotide probes, which are attached to a solid support, to 
determine sequence or to detect variations in a gene sequence or expression or for gene 
mapping. Hybridization-based approaches are high-throughput and relatively inexpensive. On 
the other side, they are based on previously discovered sequences, have high background 
levels, limited dynamic range of detection, complicated normalization, low resolution, require 
high quantities of RNA and are unsuitable for detailed transcriptomics of large genomes. 
Recently, the development of novel high-throughput DNA sequencing methods has 
provided a new method for both mapping and quantifing transcriptomes, named RNA-
sequencing (or RNA-seq). This method includes reversely transcribing a population of RNA 
molecules into cDNA with adaptors on one or both ends, which is followed by single-end or 
paired-end sequencing. The obtained reads are aligned to a reference genome or assembled de 
novo. 
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RNA-seq has several advantages compared to microarrays – it is not limited to 
detecting transcripts that correspond to a known genomic sequence, it enables discovery of 
exon connectivity (long RNA-seq reads exceed the borders of a single exon) and SNPs (due to 
high resolution), it has low background levels, high dynamic range with no upper detection 
limit and it requires less RNA material. However, there are several challenges that need to be 
taken into consideration when performing RNA-seq experiments. RNA fragmentation 
introduces bias into detection as the body of a sequence is sequenced more precisely than the 
ends. cDNA fragmentation introduces a different kind of bias because the 3'-end is sequenced 
more precisely. Amplification of fragments leads to bias in quantification; some regions are 
amplified more easily so the quantity ratios of initial RNA sequences are changed during 
amplification. Bioinformatic challenges of RNA-seq manifest in mapping alternative and 
trans-splicing and assessing repeats which need to be mapped to more than one locus in the 
genome. The latter problem can be solved by higher read lengths to include the flanking 
unique sequences. 
It is important to mention sequence coverage, or the percentage of the transcripts 
surveyed. Greater coverage requires more sequencing depth but enables more percise 
applications, such are detection of rare transcripts or variants. Generally, the more complex 
the transcriptome, the more sequencing depth is required for adequate coverage. Despite the 
challenges described above, the RNA-seq has enabled insight into some previously 
unexplored areas, such as unknown transcribed regions (especially 3'- and 5'-UTRs), 
identification of isoforms, precise 3'- and 5'-end mapping and absolute quantification of gene 
expression. 
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 Figure 1. A typical RNA-seq experiment (courtesy of Wang et al. 2009).  Long RNAs are 
first converted into a library of cDNA fragments through either RNA fragmentation or DNA 
fragmentation. Sequencing adaptors (blue) are subsequently added to each cDNA fragment 
and a short sequence is obtained from each cDNA using high-throughput sequencing 
technology. The resulting sequence reads are aligned with the reference genome or 
transcriptome, and classified as three types: exonic reads, junction reads and poly(A) end-
reads. These three types are used to generate a base-resolution expression profile for each 
gene, as illustrated at the bottom; a yeast ORF with one intron is shown. 
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4.  EPIGENOMICS 
4.1. PROTEIN-DNA INTERACTIONS AND  COVALENT HISTONE MODIFICATIONS 
  Epigenomics is the study of heritable changes other than those in the DNA sequence 
on a genome-wide level and encompasses two major modifications of DNA or chromatin: 
DNA methylation, the covalent modification of cytosine, and post-translational modification 
of histones including methylation, acetylation, phosphorylation and sumoylation.  
Determining how proteins interact with DNA to regulate gene expression is essential 
for fully understanding many biological processes and disease states. This epigenetic 
information is complementary to genotype and expression analysis. DNA-binding proteins 
play important roles in many cellular pocesses, including transcription, splicing, replication, 
DNA repair and condensation. Locations of bound factors and histone modifications cannot 
be precisely predicted from the DNA sequence alone so functional methods are necessary for 
detection of these characteristics. Chromatin immunoprecipitation coupled with short-tag 
sequencing (ChIP-seq) has become the standard method for detection of protein-DNA 
interactions and histone modifications. It has largely replaced previously used, hybridization-
based approach called ChIP-chip, which has become somewhat redundant with development 
of sequencing technologies. 
There are two versions of the most common ChIP-seq protocol, one intended for 
DNA-binding proteins and the other for histone modifications. They include crosslinking, 
fragmentation, immunoprecipitation and purification, sequencing and detection. A more 
detailed description can be found in the Figure 2.  
The success of a ChIP-seq experiment depends on the development of highly specific 
antibodies and requires a high number of cells (there are technologies coping with this 
problem, such as Nano-ChIP-seq and LinDA). Moreover, fragments derived by sonication are 
typically ∼200 bases in length while each protein typically binds only 6-20 bases. There are 
special versions of ChIP-seq developed to cope with the problem of resolution, eg. 
exonuclease from phage lambda is used to remove excess sequences flanking the binding site. 
The question of multiple proteins binding to the same site (they could be binding 
simultaneously or at different times) is solved by sequential ChIP-seq. 
Pipelines for ChIP-seq analysis are computational protocols that serve for detection 
and visualization of ChIP-seq experiment results. Regions of protein-DNA interaction or 
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histone modification are identified as DNA sites that contain enriched signals, that is, where 
more sequences are aligned than would be expected by chance. Several characteristic 
challenges need to be taken into account during analysis of ChIP-seq data. Mappability is the 
uniqueness of a stretch of DNA sequence compared with a whole-genome sequence. If the 
detected region is unique, it is easily mappable and vice versa. The problem of mappability 
can partially be solved by using paired-end reads. Another specificity of ChIP-seq data is the 
existance of three peak types – point source, broad source and mixed source. Each type 
requires a distinct strategy for detection. The need to compare data obtained in various 
experiments further complicates the ChIP-seq analysis but it serves as a way to extract 
valuable biological information, such as to detect differences in protein-DNA interactions and 
histone modifications in different cell types or environmental conditions. 
There are also a few analytical challenges. For example, signal strength depends on the 
strength of the interaction, which in turn depends on the genotype. To acquire the signal 
mean, cell from various individuals should be assayed. Moreover, the signals do not always 
represent direct but also indirect binding due to the proximity of the assayed protein and a 
non-binding sequence during the crosslinking step. This difference cannot be distinguished 
using just ChIP-seq. 
Most transcription factors cannot stably interact with binding sites if DNA is 
nucleosomal. This means that nucleosome-depleted, open chromatin regions are necessary for 
stable binding to occur. Detecting open chromatin complements ChIP-seq and two methods, 
DNase-seq and FAIRE-seq, have been developed to detect open chromatin directly. 
DNase-seq is based on the property of DNase to digest only open chromatin. It has 
been shown that open chromatin mainly corresponds to regulatory regions, like promoters, 
enhancers, silencers and insulators so this method can implicate functionality of the regions 
enriched in DNase digestion. FAIRE-seq is based on crosslinking, sonication and phenol-
chloroform extraction, after which the nucleosome-depleted fraction is segregated to the 
aqueous phase. These methods are not based on protein-DNA interaction, but they help to 
identify regions with potential protein-binding ability that were not discovered with ChIP-seq 
due to the lack of specific antibodies. 
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 Figure 2. Comparison of experimental protocols (courtesy of Furey, 2012). Experiments to 
detect different aspects of DNA-binding proteins share many of the same steps; simplified 
schematics of the main steps are shown. a  Chromatin immunoprecipitation followed by 
sequencing (ChIP–seq) for DNA-binding proteins such as transcription factors. Recent 
variations on the standard protocol include using endonuclease digestion instead of sonication 
(ChIP–exo) to increase the resolution of binding-site detection and to eliminate contaminating 
DNA, and DNA amplification after ChIP for samples with limited cells. b ChIP–seq for 
histone modifications uses micrococcal nuclease (MNase) digestion to fragment DNA and can 
also now be run on low-quantity samples when combined with the additional post-ChIP 
amplification. c DNase–seq relies on digestion by the DNaseI nuclease to identify regions of 
nucleosome-depleted open chromatin where there are binding sites for all types of factors, but 
it cannot identify what specific factors are bound. d Formaldehyde-assisted identification of 
regulatory elements (FAIRE–seq) similarly identifies nucleosome-depleted regions by 
extracting fragmented DNA that is not crosslinked to nucleosomes. LinDA, single-tube linear 
DNA amplification; T7, T7 phage RNA polymerase.  
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4.2. CHROMATIN STRUCTURE 
Methods for chromatin interactions mapping enable comprehension of regulatory 
programs and other high-complexity processes in cells that cannot be understood by using 
ChIP-seq, DNase-seq or FAIRE-seq. This includes approaches based on the chromatin 
conformation capture (commonly known as 3C) method – 3C, 4C, 5C, Hi-C and ChIA-PET. 
The aim of these approaches is to determine the frequency with which any pair of loci in the 
genome is in close enough physical proximity to become crosslinked and the principal steps 
in 3C-based experiments are to crosslink genomic regions that are in close proximity, digest 
DNA using restriction enzymes, which results in pairs of crosslinked DNA that came from 
distinct genomic locations and finally to identify these paires, for example via paired-end 
sequencing. 
3C requires PCR primers for regions of interest (low-throughput), 5C simultaneously 
uses thousands of primers to detect millions of interactions (all-by-all, high-throughput) and 
Hi-C does not depend on primers but uses biotinylated residues (genome-wide method). 
ChIA-PET (chromatin interaction analysis by paired-end tag sequencing) is used to identify 
interactions that are associated with specific proteins by using specific antibodies. It provides 
genome-wide high-resolution data for a given DNA-binding protein. The problem of all 3C 
based methods is that the resolution is limited by the frequency and distribution of restriction 
sites. 
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 Figure 3. 3C-based technologies (courtesy of Dekker et al. 2013).  In chromosome 
conformation capture (3C)-based methods (panel a of the figure), cells are crosslinked with 
formaldehyde to link chromatin segments covalently that are in close spatial proximity. Next, 
chromatin is fragmented by restriction digestion or sonication. Crosslinked fragments are then 
ligated to form unique hybrid DNA molecules. Finally, the DNA is purified and analysed. The 
different 3C-based methods differ only in the way that hybrid DNA molecules, each 
corresponding to an interaction event of a pair of loci, are detected and quantified (panel b of 
the figure). In classical 3C experiments, single ligation products are detected by PCR one at 
the time using locus-specific primers. Given that 3C can be laborious, most 3C analyses 
typically cover only tens to several hundreds of kilobases. 4C (also known as ‘circular 3C’ or 
‘3C-on-chip’) uses inverse PCR to generate genome-wide interaction profiles for single loci. 
5C combines 3C with hybrid capture approaches to identify up to millions of interactions in 
parallel between two large sets of loci: for example, between a set of promoters and a set of 
distal regulatory elements. 4C approaches are genome-wide but are anchored on a single 
locus. 5C analyses typically involve two sets of hundreds to thousands of restriction 
fragments to interrogate up to millions of long-range interactions that can cover up to tens of 
megabases and that can be contiguous or scattered among loci of interest throughout the 
genome. The Hi-C method was the first unbiased and genome-wide adaptation of 3C and 
includes a unique step in which, after restriction digestion, the staggered DNA ends are filled 
in with biotinylated nucleotides (as shown by the asterisks). This facilitates selective 
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purification of ligation junctions that are then directly sequenced. Hi-C provides a true 
all-by-all genome-wide interaction map, but the resolution of this map depends on the depth 
of sequencing. Finally, various approaches combine 3C with chromatin immunoprecipitation 
to enrich for chromatin interactions between loci bound by specific proteins of interest. For 
instance, ChIA–PET method allows for genome-wide analysis of long-range interactions 
between sites bound by a protein of interest. Because ChIA–PET data represent a selected 
subset of interactions that occur in the genome, the three analysis approaches described in this 
article cannot directly be applied to this data type. LMA, ligation-mediated amplification.  
 
5. THE ENCODE PROJECT 
ENCODE or the Encyclopedia of DNA elements is one of the biggest projects in life 
sciences, that emerged as a follow-up to the Human Genome Project. The aim of the project 
was to identify all regions of transcription, transcription factor association, chromatin 
structure and histone modification in the human genome or, in other words, to discover all 
functional elements encoded in the human genome. Functional element in genomic cotext is 
defined by the ENCODE project as a discrete genome segment that encodes a defined product 
or displays a biochemical signaure (protein binding, special chromatin structure etc.). 
ENCODE used a number of methods described in this review, such as RNA-seq, ChIP-seq, 
DNase-seq, FAIRE-seq, 5C and ChIA-PET. 
Major discoveries of the ENCODE project include the following: 80% of the human 
genome is functional, promoter functionality can explain most of the variation in RNA 
expression, non-coding regions account for more functional elements than the coding regions, 
medically relevant SNPs are enriched within non-coding functional elements and there are 4 
major groups of functional elements: sites coding for RNA molecules, regions enriched for 
histone modifications, regions of open chromatin and sites of transcription factor binding. 
 
6. CONCLUSION 
The NGS sequencing has, due to its cost effectiveness and its many different uses, 
emerged as the dominant genomics technology.  The new sequencers have provided genome-
scale sequencing capacity to individual laboratories in addition to larger genome centers, thus 
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making sequencing widely available. The short read structure of next-generation sequencers 
provides potential problems for sequence assembly particularly in areas associated with 
sequence repeats. The short read length also necessitates the development of paired-end 
sequencing approaches for improved mapping efficiency. The potential of NGS technology is 
noticeable in a wide range of aplications, from DNA-sequencing and RNA-sequencing to 
methods for assaying protein-DNA (ChIP-seq, DNase-seq, FAIRE-seq) and chromatin 
interactions (3C-based methods).  Just how important functional genomics has become is 
reflected in one of the biggest life science projects of the 21st century, the ENCODE project. 
Although the next generation sequencers are already being widely used, there are other 
sequencing methods, such as nanopore sequencing, whose scalability is being explored to 
decrease the sequencing cost and enhance throughput even further. 
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8. SUMMARY 
Over the past few years, massively parallel DNA sequencing platforms have become 
widely available, dramatically reducing the cost of DNA sequencing. The fast and low-cost 
sequencing approaches not only change the landscape of genome sequencing projects but also 
usher in new opportunities for sequencing in various applications, among other in functional 
genomics. The aim of functional genomics studies is to understand the complex relationship 
between genotype and phenotype on a genome-wide scale. Studies investigate a range of 
processes such as transcription, translation and epigenetic regulation, in an attempt to answer 
relevant biological questions. Newly developed techniques, such as RNA-seq, ChIP-seq and 
3C-based methods found their use in some of the most massive projects, such as the 
ENCODE project. The aim of this review was to introduce some of the most common 
techniques in functional genomics and to explain their possibilities, advances, applications 
and challenges. 
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